[go: up one dir, main page]

AU2734197A - Correlating polymorphic forms with multiple phenotypes - Google Patents

Correlating polymorphic forms with multiple phenotypes

Info

Publication number
AU2734197A
AU2734197A AU27341/97A AU2734197A AU2734197A AU 2734197 A AU2734197 A AU 2734197A AU 27341/97 A AU27341/97 A AU 27341/97A AU 2734197 A AU2734197 A AU 2734197A AU 2734197 A AU2734197 A AU 2734197A
Authority
AU
Australia
Prior art keywords
correlating
polymorphic forms
multiple phenotypes
phenotypes
polymorphic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27341/97A
Inventor
Stephen J. Peroutka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SPECTRA BIOMEDICAL Inc
Original Assignee
SPECTRA BIOMEDICAL Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPECTRA BIOMEDICAL Inc filed Critical SPECTRA BIOMEDICAL Inc
Publication of AU2734197A publication Critical patent/AU2734197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Zoology (AREA)
  • Ecology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Physiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
AU27341/97A 1996-04-19 1997-04-18 Correlating polymorphic forms with multiple phenotypes Abandoned AU2734197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63651796A 1996-04-19 1996-04-19
US08636517 1996-04-19
PCT/US1997/006457 WO1997040462A2 (en) 1996-04-19 1997-04-18 Correlating polymorphic forms with multiple phenotypes

Publications (1)

Publication Number Publication Date
AU2734197A true AU2734197A (en) 1997-11-12

Family

ID=24552242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27341/97A Abandoned AU2734197A (en) 1996-04-19 1997-04-18 Correlating polymorphic forms with multiple phenotypes

Country Status (4)

Country Link
EP (1) EP0897567A2 (en)
JP (1) JP2000508912A (en)
AU (1) AU2734197A (en)
WO (1) WO1997040462A2 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830655A (en) 1995-05-22 1998-11-03 Sri International Oligonucleotide sizing using cleavable primers
WO1998020166A2 (en) 1996-11-06 1998-05-14 Sequenom, Inc. Dna diagnostics based on mass spectrometry
US6635452B1 (en) 1996-12-10 2003-10-21 Sequenom Inc. Releasable nonvolatile mass label molecules
WO2000006769A2 (en) * 1998-07-25 2000-02-10 Astrazeneca Human ccr-2 gene polymorphisms
AU5876899A (en) * 1998-09-19 2000-04-10 Astrazeneca Ab Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
GB9820338D0 (en) * 1998-09-19 1998-11-11 Zeneca Ltd Chemical compounds
WO2000017393A1 (en) * 1998-09-19 2000-03-30 Astrazeneca Ab Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
EP1233364A3 (en) * 1999-06-25 2004-11-10 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US7058517B1 (en) 1999-06-25 2006-06-06 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US20030190644A1 (en) 1999-10-13 2003-10-09 Andreas Braun Methods for generating databases and databases for identifying polymorphic genetic markers
IL148930A0 (en) 1999-10-13 2002-09-12 Sequenom Inc Methods for generating databases and databases for identifying polymorphic genetic markers
GB0000992D0 (en) * 2000-01-18 2000-03-08 Astrazeneca Uk Ltd Methods
GB0001005D0 (en) * 2000-01-18 2000-03-08 Zeneca Ltd Methods
GB0000995D0 (en) * 2000-01-18 2000-03-08 Zeneca Ltd Methods
GB0002366D0 (en) * 2000-02-03 2000-03-22 Astrazeneca Uk Ltd Diagnostic method
EP1130122A3 (en) * 2000-02-17 2001-10-17 AstraZeneca AB Methods for the diagnosis of polymorphisms in the human EP1-R gene
US6931326B1 (en) 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US20040076968A1 (en) 2000-07-14 2004-04-22 Gonzalo Acuna Method for detecting pre-disposition to hepatotoxicity
GB0021667D0 (en) * 2000-09-04 2000-10-18 Glaxo Group Ltd Genetic study
EP1741722A3 (en) * 2000-10-21 2007-03-14 AstraZeneca AB Polymorphisms in the human P2X7 gene
JP2002330787A (en) * 2000-10-21 2002-11-19 Astrazeneca Ab Chemical substance
CA2872499C (en) * 2001-05-25 2016-07-05 Hitachi, Ltd. Information processing system using nucleotide sequence related information
JP2003067389A (en) * 2001-06-29 2003-03-07 Dainakomu:Kk Gene polymorphism association analysis method and program therefor
FI20021031L (en) * 2001-12-28 2003-06-29 Pertti Laehteenmaeki Vending machine
FI20012593A0 (en) * 2001-12-28 2001-12-28 Pertti Laehteenmaeki A method and system for providing a nutrition information service
DE10207971A1 (en) * 2002-02-25 2003-09-11 Norbert Dahmen Procedure for the identification of side effects relevant marker profiles
AUPS115502A0 (en) * 2002-03-18 2002-04-18 Diatech Pty Ltd Assessing data sets
EP1501863A4 (en) 2002-05-03 2007-01-24 Sequenom Inc MUTEINS OF KINASE ANCHOR PROTEINS, THEIR PEPTIDES, AND ASSOCIATED METHODS
AU2003259717A1 (en) * 2002-08-07 2004-02-25 Bristol-Myers Squibb Company Modulators of rabggt and methods of use thereof
EP1583771B1 (en) 2002-12-20 2013-04-03 Celera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits
JP2007502106A (en) * 2003-08-14 2007-02-08 マーズ インコーポレーテッド IGA allelic variant
WO2005024068A2 (en) 2003-09-05 2005-03-17 Sequenom, Inc. Allele-specific sequence variation analysis
EP2405023B1 (en) 2003-11-26 2014-01-08 Celera Corporation Genetic Polymorphisms Associated with Cardiovascular Disorders and Drug Response, Methods of Detection and Uses Thereof
US7608394B2 (en) 2004-03-26 2009-10-27 Sequenom, Inc. Methods and compositions for phenotype identification based on nucleic acid methylation
EP2395098B1 (en) 2004-03-26 2015-07-15 Agena Bioscience, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
US7820380B2 (en) 2004-05-07 2010-10-26 Celera Corporation Genetic polymorphisms associated with liver fibrosis
EP1812473A4 (en) 2004-11-16 2009-12-23 Univ Boston DUAL ENDOTHELIN-1 / ANGIOTENSIN II RECEPTOR (DEAR) FUNCTIONS IN HYPERTONIA AND ANGIOGENESIS
EP2113572B1 (en) 2005-03-11 2012-12-05 Celera Corporation Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US7695911B2 (en) 2005-10-26 2010-04-13 Celera Corporation Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
CA2915679C (en) 2006-10-20 2017-12-12 Celera Corporation Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
US8039212B2 (en) 2007-11-05 2011-10-18 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
US20090221620A1 (en) 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
WO2010006215A1 (en) 2008-07-09 2010-01-14 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
CN102770140B (en) 2009-08-21 2017-06-23 诺瓦蒂斯公司 The method for the treatment of cancer
US20110269735A1 (en) 2010-04-19 2011-11-03 Celera Corporation Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
GB201008727D0 (en) 2010-05-25 2010-07-07 Glaxo Group Ltd Biomarkers
US9646134B2 (en) 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
KR102042253B1 (en) 2010-05-25 2019-11-07 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Bambam: parallel comparative analysis of high-throughput sequencing data
US20120108651A1 (en) 2010-11-02 2012-05-03 Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
CN104204226A (en) 2012-01-31 2014-12-10 史密斯克莱.比奇曼（科克）有限公司 ways to treat cancer
EP3174995B1 (en) 2014-07-30 2020-08-19 F.Hoffmann-La Roche Ag Genetic markers for predicting responsiveness to therapy with hdl-raising or hdl mimicking agent

Also Published As

Publication number Publication date
EP0897567A2 (en) 1999-02-24
WO1997040462A3 (en) 1998-03-05
WO1997040462A2 (en) 1997-10-30
JP2000508912A (en) 2000-07-18

Similar Documents

Publication Publication Date Title
AU2734197A (en) Correlating polymorphic forms with multiple phenotypes
AU2841197A (en) Icing set
AU8827398A (en) Protective coverings
AU4040197A (en) Microturbomachinery
AU3387997A (en) Autonotification
AU2845197A (en) Cycloalkano-pyridines
AU4945197A (en) Aminothiophenecarboxamides
AU3102797A (en) Cell adhesion inhibiting compounds
AU4013397A (en) Arylalkanoylpyridazines
AU2684197A (en) Handleset
AU4176997A (en) 3-alkyl-3-phenyl-piperidines
AU4218597A (en) Superseat
AU4460497A (en) Mycosis vaccines
AU2090897A (en) Hydroxyhexahydropyridazines
AU1761797A (en) Corrosion preventing covering
AU3130597A (en) Tristetraprolin
AU2237197A (en) Fishing-lure
AU4332497A (en) Endo-beta-galactosidase
AU1900097A (en) Cremators
AU3557397A (en) Double-tau-profile
AU1597197A (en) Thienoquinolines
AU2895097A (en) New thiazolopyridines
AU5002897A (en) Gripper-accumulator
AU1643797A (en) Repeater-system
AU3155797A (en) Constructional element